These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 1451224)
1. The use of muscle relaxants in the intensive care unit. Sharpe MD Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224 [TBL] [Abstract][Full Text] [Related]
2. Neuromuscular blocking agents in the neurosurgical intensive care unit. Ohlinger MJ; Rhoney DH Surg Neurol; 1998 Feb; 49(2):217-21. PubMed ID: 9457275 [TBL] [Abstract][Full Text] [Related]
3. [Muscle relaxants in the ICU]. Schneider G Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945 [TBL] [Abstract][Full Text] [Related]
5. Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit. Durbin CG Crit Care Clin; 1991 Jul; 7(3):489-506. PubMed ID: 1863878 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of neuromuscular blocking agents in the intensive care unit. Hanson CW Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926 [TBL] [Abstract][Full Text] [Related]
10. Neuromuscular-blocking drugs. Use and misuse in the intensive care unit. Murphy GS; Vender JS Crit Care Clin; 2001 Oct; 17(4):925-42. PubMed ID: 11762268 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blockers in surgery and intensive care, Part 2. McManus MC Am J Health Syst Pharm; 2001 Dec; 58(24):2381-95. PubMed ID: 11794954 [TBL] [Abstract][Full Text] [Related]
12. Clinical uses and controversies of neuromuscular blocking agents in infants and children. Martin LD; Bratton SL; O'Rourke PP Crit Care Med; 1999 Jul; 27(7):1358-68. PubMed ID: 10446832 [TBL] [Abstract][Full Text] [Related]
13. Rocuronium vs. succinylcholine in the emergency department: a critical appraisal. Mallon WK; Keim SM; Shoenberger JM; Walls RM J Emerg Med; 2009 Aug; 37(2):183-8. PubMed ID: 19097730 [TBL] [Abstract][Full Text] [Related]
14. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular blocking agents in the intensive care unit: a two-edged sword. Sladen RN Crit Care Med; 1995 Mar; 23(3):423-8. PubMed ID: 7874888 [No Abstract] [Full Text] [Related]
17. [Short acting muscle relaxants: is neuromuscular monitoring still necessary?]. Blobner M Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):348-54; quiz 356, 378. PubMed ID: 19440944 [TBL] [Abstract][Full Text] [Related]
18. [Use of the muscle relaxant in the intensive care unit]. Nakatsuka H; Shimizu K; Sato T Masui; 2008 Jul; 57(7):853-9. PubMed ID: 18649640 [TBL] [Abstract][Full Text] [Related]
19. [Use of muscle relaxants in intensive care: indications and contraindications]. Forster A; Suter PM Klin Anasthesiol Intensivther; 1980; 22():244-51. PubMed ID: 6449623 [No Abstract] [Full Text] [Related]
20. Review of Continuous Infusion Neuromuscular Blocking Agents in the Adult Intensive Care Unit. Smetana KS; Roe NA; Doepker BA; Jones GM Crit Care Nurs Q; 2017; 40(4):323-343. PubMed ID: 28834856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]